Free Trial

Q3 2024 Earnings Estimate for DocGo Inc. Issued By Northland Capmk (NASDAQ:DCGO)

→ What’s Pelosi Buying Now? (From Altimetry) (Ad)

DocGo Inc. (NASDAQ:DCGO - Free Report) - Analysts at Northland Capmk lowered their Q3 2024 earnings estimates for DocGo in a research report issued to clients and investors on Wednesday, May 8th. Northland Capmk analyst M. Latimore now expects that the company will earn $0.05 per share for the quarter, down from their previous forecast of $0.07. The consensus estimate for DocGo's current full-year earnings is $0.31 per share. Northland Capmk also issued estimates for DocGo's Q4 2024 earnings at $0.04 EPS, FY2024 earnings at $0.24 EPS and FY2025 earnings at $0.16 EPS.

DocGo (NASDAQ:DCGO - Get Free Report) last posted its earnings results on Wednesday, February 28th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.13 by ($0.07). The business had revenue of $199.25 million for the quarter, compared to analyst estimates of $195.48 million. DocGo had a return on equity of 2.01% and a net margin of 1.10%.

Several other equities research analysts also recently issued reports on DCGO. Cantor Fitzgerald lowered their price target on DocGo from $11.00 to $5.00 and set an "overweight" rating on the stock in a research report on Thursday. Canaccord Genuity Group lowered their price target on DocGo from $9.00 to $5.00 and set a "buy" rating on the stock in a research report on Thursday. BTIG Research lowered their price target on DocGo from $11.00 to $7.00 and set a "buy" rating on the stock in a research report on Thursday. Needham & Company LLC lowered their price target on DocGo from $10.00 to $7.00 and set a "buy" rating on the stock in a research report on Thursday. Finally, Stifel Nicolaus lowered their price target on DocGo from $8.00 to $6.50 and set a "buy" rating on the stock in a research report on Tuesday, April 30th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat.com, DocGo has a consensus rating of "Buy" and a consensus target price of $7.75.


View Our Latest Stock Report on DocGo

DocGo Trading Down 1.8 %

DocGo stock traded down $0.06 during mid-day trading on Friday, hitting $3.02. 1,477,197 shares of the company's stock were exchanged, compared to its average volume of 1,026,547. The stock has a market cap of $314.59 million, a P/E ratio of 43.14, a P/E/G ratio of 0.42 and a beta of 0.96. DocGo has a 1-year low of $2.78 and a 1-year high of $10.82. The stock has a 50 day moving average of $3.66 and a two-hundred day moving average of $4.39.

Institutional Investors Weigh In On DocGo

A number of institutional investors have recently added to or reduced their stakes in DCGO. AJOVista LLC bought a new position in DocGo during the fourth quarter worth about $25,000. Victory Capital Management Inc. bought a new position in DocGo during the third quarter worth about $55,000. Cape Investment Advisory Inc. bought a new position in DocGo during the fourth quarter worth about $63,000. Verdence Capital Advisors LLC bought a new position in DocGo during the first quarter worth about $64,000. Finally, Envestnet Portfolio Solutions Inc. bought a new position in DocGo during the third quarter worth about $67,000. 56.44% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Michael J. Burdiek bought 10,000 shares of the firm's stock in a transaction that occurred on Thursday, March 14th. The shares were acquired at an average cost of $3.61 per share, with a total value of $36,100.00. Following the completion of the transaction, the director now directly owns 571,595 shares in the company, valued at $2,063,457.95. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 13.78% of the stock is owned by company insiders.

DocGo Company Profile

(Get Free Report)

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

See Also

Should you invest $1,000 in DocGo right now?

Before you consider DocGo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.

While DocGo currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Featured Articles and Offers

Search Headlines: